A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic.
A contributed article by EMEA CRO Merlin Piscitelli on M&A trends, predictions and challenges for the life sciences sector was published in the September issue of Pharma Times. The article highlights some of the key trends that are set to drive deals through 2021, including acceleration of digital health and changes in regulations.
CEO Rusty Wiley discusses Datasite’s growth and strategy outlook with Mergermarket. The article features comments from Rusty on the company’s ambition to support the entire M&A lifecycle, from the inception of a deal, through marketing the asset and due diligence, to closing the deal and post-deal content sharing, through acquisitions and other activities.